{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:25Z","timestamp":1786119625910,"version":"build-2736575974"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10,23]]},"DOI":"10.1097\/qad.0b013e32833e922c","type":"journal-article","created":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T04:18:03Z","timestamp":1284697083000},"page":"2499-2506","source":"Crossref","is-referenced-by-count":8,"title":["The MMP1 (\u221216071G\/2G) single nucleotide polymorphism associates with the HAART-related lipodystrophic syndrome"],"prefix":"10.1097","volume":"24","author":[{"given":"Angel H","family":"Montes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eulalia","family":"Valle-Garay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Suarez-Zarracina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Melon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A","family":"Carton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Collazos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Asensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210130","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"R2-9-20210130","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","article-title":"Risk of lipodystrophy in HIV-1 infected patients treated with protease inhibitors: a prospective cohort study","volume":"357","author":"Martinez","year":"2001","journal-title":"Lancet"},{"key":"R3-9-20210130","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1097\/00002030-200304001-00017","article-title":"HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management","volume":"17","author":"Carr","year":"2003","journal-title":"AIDS"},{"key":"R4-9-20210130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.qai.0000167478.28051.3a","article-title":"Redefining lipodystrophy syndrome: risks and impact on clinical decision making","volume":"39","author":"Lichtenstein","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R5-9-20210130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"key":"R6-9-20210130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1086\/421774","article-title":"Perirenal fat diameter measured by echography could be an early predictor of lipodystrophy in HIV-infected patients receiving highly active antiretroviral therapy","volume":"39","author":"Asensi","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R7-9-20210130","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","article-title":"A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome","volume":"14","author":"Carr","year":"2000","journal-title":"AIDS"},{"key":"R8-9-20210130","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"R9-9-20210130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00126334-200207010-00002","article-title":"Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat","volume":"30","author":"Cherry","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-9-20210130","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1097\/00002030-200109280-00009","article-title":"Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy","volume":"15","author":"Shikuma","year":"2001","journal-title":"AIDS"},{"key":"R11-9-20210130","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00002030-200306130-00007","article-title":"Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy","volume":"17","author":"Nolan","year":"2003","journal-title":"AIDS"},{"key":"R12-9-20210130","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00002030-199905070-00009","article-title":"Reversion of metabolic abnormalities after switching from HIV-protease inhibitors to nevirapine","volume":"13","author":"Martinez","year":"1999","journal-title":"AIDS"},{"key":"R13-9-20210130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jama.288.2.207","article-title":"Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial","volume":"288","author":"Carr","year":"2002","journal-title":"JAMA"},{"key":"R14-9-20210130","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/QAD.0b013e32832b4377","article-title":"Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment","volume":"23","author":"Haubrich","year":"2009","journal-title":"AIDS"},{"key":"R15-9-20210130","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/QAD.0b013e32830b3a96","article-title":"Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy","volume":"22","author":"Zanone Poma","year":"2008","journal-title":"AIDS"},{"key":"R16-9-20210130","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1097\/QAD.0b013e32830a9886","article-title":"Genetic analysis implicates resistin in HIV lipodystrophy","volume":"22","author":"Ranade","year":"2008","journal-title":"AIDS"},{"key":"R17-9-20210130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/GIM.0b013e3181632713","article-title":"IL-1\u03b2 (+3954 C\/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome","volume":"10","author":"Asensi","year":"2008","journal-title":"Genet Med"},{"key":"R18-9-20210130","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1097\/00002030-200210180-00005","article-title":"TNF\u03b1 promoter region gene polymorphisms in HIV-positive patients with lipodystrophy","volume":"16","author":"Maher","year":"2002","journal-title":"AIDS"},{"key":"R19-9-20210130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00002030-200301030-00017","article-title":"Tumour necrosis factor-alpha gene \u2212238 G\/A promoter polymorphism associated with a more rapid onset of lipodystrophy","volume":"17","author":"Nolan","year":"2003","journal-title":"AIDS"},{"key":"R20-9-20210130","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/135965350701200714","article-title":"Toxicogenetics of antiretroviral therapy: genetic factors that contribute to metabolic complications","volume":"12","author":"Tarr","year":"2007","journal-title":"Antivir Ther"},{"key":"R21-9-20210130","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nri1418","article-title":"Matrix metalloproteinases as modulators of inflammation and innate immunity","volume":"4","author":"Parks","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"R22-9-20210130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1152\/ajpendo.00056.2003","article-title":"Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy","volume":"286","author":"Johnson","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R23-9-20210130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2249.2005.02840.x","article-title":"The paradox of matrix metalloproteinases in infectious diseases","volume":"142","author":"Elkington","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"R24-9-20210130","first-page":"5321","article-title":"A single nucleotide polymorphism in the matrix metalloproteinase-1 creates an Ets binding site and augments transcription","volume":"58","author":"Rutter","year":"1998","journal-title":"Cancer Res"},{"key":"R25-9-20210130","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1046\/j.1432-1033.2003.03821.x","article-title":"Fra-1 targets the AP-1 site\/2G single nucleotide polymorphism (ETS site) in the MMP1 promoter","volume":"270","author":"Tower","year":"2003","journal-title":"Eur J Biochem"},{"key":"R26-9-20210130","first-page":"4225","article-title":"Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion\/deletion polymorphism in its promoter region","volume":"59","author":"Kanamori","year":"1999","journal-title":"Cancer Res"},{"key":"R27-9-20210130","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1359\/jbmr.091013","article-title":"A functional polymorphism in MMP1 could influence osteomyelitis development","volume":"25","author":"Montes","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R28-9-20210130","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/QAD.0b013e328018751d","article-title":"Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients","volume":"21","author":"Latronico","year":"2007","journal-title":"AIDS"},{"key":"R29-9-20210130","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1124\/jpet.104.077263","article-title":"Protease inhibitor treatments reveal specific involvement of matrix metalloproteinase-9 in human adipocyte differentiation","volume":"312","author":"Bourlier","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R30-9-20210130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1124\/jpet.106.111849","article-title":"Inhibition of human preadipocyte proteosomal activity by HIV protease inhibitors or specific inhibitor lactacystin leads to a defect in adipogenesis, which involves matrix metalloproteinase-9","volume":"320","author":"De Barros","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"R31-9-20210130","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1073\/pnas.0704212104","article-title":"HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells","volume":"104","author":"Coffinier","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R32-9-20210130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbrc.2008.07.033","article-title":"HIV-protease inhibitors block the enzymatic activity of purified Ste24p","volume":"374","author":"Hudon","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"R33-9-20210130","doi-asserted-by":"crossref","first-page":"9797","DOI":"10.1074\/jbc.M709629200","article-title":"A potent HIV protease inhibitor, darunavir, does not inhibit ZMPSTE24 or lead to an accumulation of farnesyl-prealamin A in cells","volume":"283","author":"Coffinier","year":"2008","journal-title":"J Biol Chem"},{"key":"R34-9-20210130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/tpj.2009.13","article-title":"A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients","volume":"9","author":"Demacq","year":"2009","journal-title":"Pharmacogenom J"},{"key":"R35-9-20210130","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population","volume":"15","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"key":"R36-9-20210130","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1089\/aid.2006.22.830","article-title":"Association between physical and echographic fat thickness assessments and a lipodystrophy grading scale in lypodystrophic HIV patients. Practical implications","volume":"22","author":"Asensi","year":"2006","journal-title":"AIDS Res Human Retroviruses"},{"key":"R37-9-20210130","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.2337\/diabetes.50.9.2080","article-title":"Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation","volume":"50","author":"Bouloumi\u00e9","year":"2001","journal-title":"Diabetes"},{"key":"R38-9-20210130","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.bbrc.2009.08.024","article-title":"YKL-40 secreted from adipose tissue inhibits degradation of type I collagen","volume":"388","author":"Iwata","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"R39-9-20210130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cca.2008.06.012","article-title":"Matrix metalloproteinase-1 promoter is associated with body mass index in Korean population with aged or equal to 50 years","volume":"396","author":"Nho","year":"2008","journal-title":"Clin Chim Acta"},{"issue":"Suppl 4","key":"R40-9-20210130","first-page":"A23","article-title":"Comparison of the effects of lopinavir\/ritonavir and efavirenz on gene expression and differentiation of human adipocytes. [abstract P-01]. In: 10th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. London, UK 2008","volume":"13","author":"Diaz-Delfin","year":"2008","journal-title":"Antiviral Ther"},{"key":"R41-9-20210130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00042560-200107010-00005","article-title":"Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy","volume":"27","author":"Duong","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R42-9-20210130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/00365540310008393","article-title":"Factors influencing the development of lipodystrophy in human immunodeficiency virus-infected patients","volume":"35","author":"Collazos","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"R43-9-20210130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/QAI.0b013e3180423a95","article-title":"Association between hepatitis C virus coinfection and regional adipose tissue volume in HIV-infected men and women","volume":"45","author":"Tien","year":"2007","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAD.0b013e32833e922c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:36:14Z","timestamp":1786041374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201010230-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,23]]},"references-count":43,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32833e922c","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10,23]]}}}